Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies.
Li
Jin
J
Department of Medical Oncology, Fudan University Shanghai Cancer Center, PR China. fudanlijin@163.com
Zhao
Xinmin
X
Chen
Lei
L
Guo
Haiyi
H
Lv
Fangfang
F
Jia
Ka
K
Yv
Ke
K
Wang
Fengqing
F
Li
Chuan
C
Qian
Jun
J
Zheng
Chunlei
C
Zuo
Yunxia
Y